Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Sickle Beta Plus Thalassemia Disease
source: New England Pediatric Sickle Cell Consortium
year: 2017
summary/abstract:Sickle Beta + Thalassemia (Sickle BA-ta Plus Thal-a-SEE-me-a) is a “mild” form of sickle cell disease. Your child’s red blood cells contain an abnormal hemoglobin called hemoglobin S or sickle hemoglobin in addition to a small amount of the normal hemoglobin called hemoglobin A. The red blood cells have a defect called beta plus thalassemia, which results in cells which are small in size and more pale than usual.
Instead of appearing round or donut shaped, your child’s red blood cells are somewhat small, pale, and misshapen. Some may appear sickled or banana shaped.
Because sickle beta plus thalassemia is inherited, it is a lifelong disorder. There is no treatment or cure. Your child will always have a mild anemia or slightly low blood count. This may cause occasional tiredness or weakness.
read more
+myBinderRelated Content
-
How Is Sickle Cell Disease Diagnosed?People who do not know whether they make...
-
Iron, inflammation, and early death in adults with sickle cell diseaseRATIONALE: Patients with sickle cell dis...
-
New digital education platform for the SCD communityhttps://www.onescdvoice.com/wp-content/u...
-
Sickle Cell Stories: Office of Minority Health, U.S. Department of Health and Human Serviceshttps://www.youtube.com/watch?v=HFojyaji...
-
Environmental, genetic factors may predict longevity in sickle cell diseaseA case series of individuals with sickle...
-
Indiana Sickle Cell Conference 2020 – VirtualThis one-day conference will provide hel...
-
Debunking the Myths About Sickle Cell Diseasehttps://www.youtube.com/watch?v=OZMwkE-W...
Don’t forget to join the oneSCDvoice community!
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.